TRWWSLAJSW
ASAWPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
89bio89bio.com |
89bio is a biopharmaceutical company developing pegozafermin, an FGF21 analog being evaluated in Phase 3 trials for Metabolic Dysf | San Francisco, California | 51-200 | — |
Madrigal Pharmaceuticalsmadrigalpharma.com  UF MCDS |
Madrigal Pharmaceuticals is a biopharmaceutical company developing novel therapeutics for metabolic dysfunction-associated steatoh | Conshohocken, Pennsylvania | 1001-5000 | — |
Regeneronregeneron.com SM  HH BH |
Regeneron is a biopharmaceutical company that invents, develops, and commercializes life-transforming medicines for people with se | Tarrytown, New York | 5000+ | — |
Biogenbiogen.com RWAF  PS |
Biogen is a biotechnology company founded in 1978 and headquartered in Cambridge, Massachusetts, that develops first-in-class medi | Cambridge, Massachusetts | 5000+ | — |
Viking Therapeuticsvikingtherapeutics.com |
Viking Therapeutics is a clinical-stage biopharmaceutical company developing novel first-in-class and best-in-class therapies for | San Diego, California | 51-200 | — |
Amgenamgen.com  CMDKJS |
Amgen is a biotechnology pioneer that uses living cells to make biologic medicines, with a research pipeline treating cancer, hear | Thousand Oaks, California | 5000+ | — |
Akeroakero.com |
— | — | — | |
Genentechgenentech.com |
— | — | — | |
Boehringer Ingelheimboehringer-ingelheim.com |
— | — | — | |
Novo Nordisknovo-nordisk.com |
— | — | — | |
Novartisnovartis.com  AABV LM |
Novartis is an innovative medicines company that discovers and commercializes medicines across cardiovascular, renal and metabolic | — | — | — |
Rocheroche.com  CK JB NT |
— | — | — | |
Sagimet Biosciencessagimet.com |
Sagimet Biosciences is a clinical-stage biopharmaceutical company developing oral FASN inhibitor therapeutics, with lead candidate | San Mateo, California | 11-50 | — |
AbbVieabbvie.com SV  CR EF |
AbbVie is a global biopharmaceutical company that discovers and delivers innovative medicines and solutions for complex health iss | North Chicago, Illinois | 5000+ | — |
Inventiva Pharmainventivapharma.com |
Inventiva is a clinical-stage biotechnology company developing lanifibranor, a novel oral investigational therapy for Metabolic Dy | Daix, Bourgogne-Franche-Comté | 51-200 | — |
Elysium Healthelysiumhealth.com |
Elysium Health is a longevity science company that develops health products from natural compounds, translating advances in scienc | New York, New York | 51-200 | — |
Pregenenbluebirdbio.com |
Genetix Biotherapeutics (formerly bluebird bio) is a privately held, Boston-area gene therapy company developing first-in-class, o | Seattle, Washington | 1-10 | — |
Vertexvertex.com |
Vertex is an AI consulting and cloud technology services firm based in Austin, Texas, offering services across cloud technology, a | Austin, Texas | 11-50 | — |
Alnylamalnylam.com |
Alnylam is a leading independent biopharmaceutical company and the pioneer in RNAi therapeutics, developing medicines that silence | Cambridge, Massachusetts | 1001-5000 | — |
Modernamoderna.com |
— | — | — | |
Akero Therapeuticsakerotx.com |
Akero Therapeutics is a clinical-stage biopharmaceutical company developing Efruxifermin (EFX), a novel therapy for metabolic dysf | South San Francisco, California | 51-200 | — |
Biomea Fusionbiomeafusion.com |
Biomea Fusion is a clinical-stage biotechnology company developing oral small molecule therapies, icovamenib and BMF-650, for diab | San Carlos, California | 51-200 | — |
Altimmunealtimmune.com |
Altimmune is a late clinical-stage biopharmaceutical company developing therapies for serious liver diseases, with its lead progra | Gaithersburg, Maryland | 51-200 | — |
Axcella Healthaxcellahealth.com |
Axcella Health is a clinical-stage biotechnology company in Littleton, Massachusetts, developing product candidates based on endog | Littleton, Massachusetts | 51-200 | — |
Linxis Biopharmaceuticalslinxispharmaceuticals.com |
LinXis Biopharmaceuticals is a biopharmaceutical company developing Fibrobodies® — small, selective small-molecule vectors that ta | Amsterdam, North Holland | 201-1000 | — |
Angionangion.com |
Angion is a late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecu | Uniondale, New York | 11-50 | — |
Chemomab Therapeuticschemomab.com |
Chemomab Therapeutics is a biopharmaceutical company founded in 2011 and based in Tel Aviv, developing innovative treatments for p | Tel Aviv, Tel Aviv District | 51-200 | — |
3-v Biosciences3vbio.com |
3vbio.com is a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic pathways, | San Mateo, California | 51-200 | — |
Artus Therapeuticsartustx.com |
Artus Therapeutics is a pre-clinical stage biotech company developing first-in-class oral small molecule therapeutics for inflamma | Boston, Massachusetts | 1-10 | — |
CORXEL Pharmaceuticalscorxelbio.com |
CORXEL is a clinical-stage biopharmaceutical company developing innovative therapies for patients with cardiometabolic conditions, | Berkeley Heights, New Jersey | 51-200 | — |
| Run live for more | ||||
89bio is a biopharmaceutical company developing pegozafermin, an FGF21 analog being evaluated in Phase 3 trials for Metabolic Dysfunction-Associated Steatohepatitis (MASH) and severe hypertriglyceridemia (SHTG). The company was acquired by Roche in September 2025 and is now part of Roche's Pharmaceuticals Division.
Companies like 89bio include Madrigal Pharmaceuticals, Regeneron, Biogen, Viking Therapeutics, Amgen. See the full list of 24 competitors and alternatives above.
89bio has approximately 51-200 employees and is in the Biotechnology Research industry.
89bio is headquartered in San Francisco, California.
89bio operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at 89bio are listed above, including leaders across executive, finance, sales and operations.